Role of Insulin-like Growth Factor 1 Receptor Signalling in Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 2005 Jun 16

PMID 15956962

Citations 82

Authors

O Larsson

A Girnita

L Girnita

Affiliations

Soon will be listed here.

Abstract

The insulin-like growth factor (IGF-1) signalling is highly implicated in cancer. In this signalling the IGF-1 receptor (IGF-1R) is unquestionable, the predominating single factor. IGF-1R is crucial for tumour transformation and survival of malignant cell, but is only partially involved in normal cell growth. This is in part due to the interactions with oncogenes. Recent findings suggest a close interplay with the p53/MDM2 pathway. Disturbances in components in the p53/MDM2/IGF-1R network may cause IGF-1R upregulation and growth advantage for the cancer cell. Targeting of IGF-1R is more and more seen as a promising option for future cancer therapy. Single chain antibodies and small molecules with selective effects on IGF-1R dependent malignant growth are of particular interest. Forthcoming clinical trials are welcome and will indeed be the only way to evaluate the impact of IGF-1R targeting in human cancer.

Citing Articles

Regulation of pro-apoptotic and anti-apoptotic factors in obesity-related esophageal adenocarcinoma.

Agrawal S, Podber A, Gillespie M, Dietz N, Hansen L, Nandipati K Mol Biol Rep. 2024; 51(1):1049.

PMID: 39395071 PMC: 11470870. DOI: 10.1007/s11033-024-09931-6.

Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma.

Hassan M, Johnson C, Ponna S, Scofield D, Awasthi N, von Holzen U Cancers (Basel). 2024; 16(18).

PMID: 39335147 PMC: 11430189. DOI: 10.3390/cancers16183175.

Structural Models for a Series of Allosteric Inhibitors of IGF1R Kinase.

Verma J, Vashisth H Int J Mol Sci. 2024; 25(10).

PMID: 38791406 PMC: 11121299. DOI: 10.3390/ijms25105368.

Structural Models for a Series of Allosteric Inhibitors of IGF1R Kinase.

Verma J, Vashisth H bioRxiv. 2024; .

PMID: 38617226 PMC: 11014618. DOI: 10.1101/2024.04.04.588115.

Role of Insulin-like Growth Factor-1 Receptor in Tobacco Smoking-Associated Lung Cancer Development.

Shahid A, Santos S, Lin C, Huang Y Biomedicines. 2024; 12(3).

PMID: 38540176 PMC: 10967781. DOI: 10.3390/biomedicines12030563.

References

Kato H, Faria T, STANNARD B, Roberts Jr C, LeRoith D . Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). J Biol Chem. 1993; 268(4):2655-61. View

Karnieli E, Werner H, Rauscher 3rd F, Benjamin L, LeRoith D . The IGF-I receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms' tumor 1 fusion protein. J Biol Chem. 1996; 271(32):19304-9. DOI: 10.1074/jbc.271.32.19304. View

Zhang L, Kashanchi F, Zhan Q, Zhan S, Brady J, Fornace A . Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis. Cancer Res. 1996; 56(6):1367-73. View

Clarke R, Howell A, Anderson E . Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone. Br J Cancer. 1997; 75(2):251-7. PMC: 2063278. DOI: 10.1038/bjc.1997.41. View

Mayo L, Donner D . A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci U S A. 2001; 98(20):11598-603. PMC: 58775. DOI: 10.1073/pnas.181181198. View

Brodt P, Samani A, Navab R . Inhibition of the type I insulin-like growth factor receptor expression and signaling: novel strategies for antimetastatic therapy. Biochem Pharmacol. 2000; 60(8):1101-7. DOI: 10.1016/s0006-2952(00)00422-6. View

Dunn S, Ehrlich M, Sharp N, Reiss K, Solomon G, Hawkins R . A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res. 1998; 58(15):3353-61. View

Kubbutat M, Jones S, Vousden K . Regulation of p53 stability by Mdm2. Nature. 1997; 387(6630):299-303. DOI: 10.1038/387299a0. View

Zhao H, Dupont J, Yakar S, Karas M, LeRoith D . PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells. Oncogene. 2004; 23(3):786-94. DOI: 10.1038/sj.onc.1207162. View

10.

Werner H, Shen-Orr Z, Rauscher 3rd F, Morris J, Roberts Jr C, LeRoith D . Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol Cell Biol. 1995; 15(7):3516-22. PMC: 230588. DOI: 10.1128/MCB.15.7.3516. View

11.

Girnita L, Girnita A, Brodin B, Xie Y, Nilsson G, Dricu A . Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact. Cancer Res. 2000; 60(18):5278-83. View

12.

Adams T, Epa V, Garrett T, Ward C . Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci. 2000; 57(7):1050-93. PMC: 11146944. DOI: 10.1007/PL00000744. View

13.

Baserga R . The contradictions of the insulin-like growth factor 1 receptor. Oncogene. 2000; 19(49):5574-81. DOI: 10.1038/sj.onc.1203854. View

14.

Kalebic T, Tsokos M, Helman L . In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2. Cancer Res. 1994; 54(21):5531-4. View

15.

Lee Y, Han Y, Lee S, Lee Y, Park S, Park Y . Activation of insulin-like growth factor II signaling by mutant type p53: physiological implications for potentiation of IGF-II signaling by p53 mutant 249. Mol Cell Endocrinol. 2003; 203(1-2):51-63. DOI: 10.1016/s0303-7207(03)00117-5. View

16.

Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R . Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res. 1994; 54(8):2218-22. View

17.

Olchovsky D, Song J, Gelato M, Sherwood J, Spatola E, Bruno J . Pituitary and hypothalamic insulin-like growth factor-I (IGF-I) and IGF-I receptor expression in food-deprived rats. Mol Cell Endocrinol. 1993; 93(2):193-8. DOI: 10.1016/0303-7207(93)90123-2. View

18.

Vousden K, Prives C . P53 and prognosis: new insights and further complexity. Cell. 2005; 120(1):7-10. DOI: 10.1016/j.cell.2004.12.027. View

19.

Werner H, STANNARD B, Bach M, Roberts Jr C, LeRoith D . Regulation of insulin-like growth factor I receptor gene expression in normal and pathological states. Adv Exp Med Biol. 1991; 293:263-72. DOI: 10.1007/978-1-4684-5949-4_24. View

20.

LeRoith D, Roberts Jr C . The insulin-like growth factor system and cancer. Cancer Lett. 2003; 195(2):127-37. DOI: 10.1016/s0304-3835(03)00159-9. View